Skip to main content

Closed

RGC: Regencell Bioscience Holdings Limited Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

3thpctl

Volume

0.67×avg

Market Cap

3.06BUSD

P/E Ratio

-435.2TTM

Div Yield

-ann

Regencell Bioscience Holdings Limited

RGCNASDAQ Capital Market·USD·Closed

Regencell Bioscience Holdings Limited

RGCNASDAQ·USD·Closed

$6.18

+4.04%

$6.18

+$0.24 (4.04%)

52W Range

3thpctl

Volume

0.67×avg

Mkt Cap

3.06BUSD

P/E

-435.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings